Keveyis is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xeris Pharmaceuticals, Inc.. The primary component is Dichlorphenamide.
Product ID | 72065-001_d30a8795-39d2-51c3-e053-2995a90abcf0 |
NDC | 72065-001 |
Product Type | Human Prescription Drug |
Proprietary Name | Keveyis |
Generic Name | Dichlorphenamide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2021-12-13 |
Marketing Category | NDA / |
Application Number | NDA011366 |
Labeler Name | Xeris Pharmaceuticals, Inc. |
Substance Name | DICHLORPHENAMIDE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS],Carbonic Anhydrase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-12-13 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
51672-4177 | Keveyis | Dichlorphenamide |
71090-001 | Keveyis | Dichlorphenamide |
72065-001 | Keveyis | Dichlorphenamide |
51672-4144 | DARANIDE | dichlorphenamide |
13668-676 | Dichlorphenamide | Dichlorphenamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KEVEYIS 86724075 5034655 Live/Registered |
TARO PHARMACEUTICALS U.S.A., INC. 2015-08-13 |